Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

Authors: Daniel J. Wallace, Richard Furie, Yoshiya Tanaka, Kenneth Kalunian, Marta Mosca, Michelle Petri, Thomas Dörner, Mario H. Cardiel, Ian N Bruce, Elisa Gómez, Tara Carmack, Amy M. DeLozier, Jonathan Janes, Matthew D. Linnik, Stephanie de Bono, Maria Silk, Robert W. Hoffman - The Lancet 2018 cited by 513